210 related articles for article (PubMed ID: 29544473)
1. Correlation of trans fatty acids with the severity of coronary artery disease lesions.
Hadj Ahmed S; Kharroubi W; Kaoubaa N; Zarrouk A; Batbout F; Gamra H; Najjar MF; Lizard G; Hininger-Favier I; Hammami M
Lipids Health Dis; 2018 Mar; 17(1):52. PubMed ID: 29544473
[TBL] [Abstract][Full Text] [Related]
2. Association of plasma fatty acid alteration with the severity of coronary artery disease lesions in Tunisian patients.
Hadj Ahmed S; Kaoubaa N; Kharroubi W; Zarrouk A; Najjar MF; Batbout F; Gamra H; Lizard G; Hammami M
Lipids Health Dis; 2017 Aug; 16(1):154. PubMed ID: 28806974
[TBL] [Abstract][Full Text] [Related]
3. Serum Trans-Fatty Acid Concentration Is Elevated in Young Patients With Coronary Artery Disease in Japan.
Mori K; Ishida T; Yasuda T; Hasokawa M; Monguchi T; Sasaki M; Kondo K; Nakajima H; Shinohara M; Shinke T; Irino Y; Toh R; Nishimura K; Hirata K
Circ J; 2015; 79(9):2017-25. PubMed ID: 26166015
[TBL] [Abstract][Full Text] [Related]
4. Effects of L-carnitine supplementation on oxidative stress and antioxidant enzymes activities in patients with coronary artery disease: a randomized, placebo-controlled trial.
Lee BJ; Lin JS; Lin YC; Lin PT
Nutr J; 2014 Aug; 13():79. PubMed ID: 25092108
[TBL] [Abstract][Full Text] [Related]
5. Identification of long and very long chain fatty acids, plasmalogen-C16:0 and phytanic acid as new lipid biomarkers in Tunisian coronary artery disease patients.
Hadj Ahmed S; Koubaa N; Kharroubi W; Zarrouk A; Mnari A; Batbout F; Gamra H; Hammami S; Lizard G; Hammami M
Prostaglandins Other Lipid Mediat; 2017 Jul; 131():49-58. PubMed ID: 28789919
[TBL] [Abstract][Full Text] [Related]
6. Correlation of antioxidants with lipid peroxidation and lipid profile in patients suffering from coronary artery disease.
Gupta S; Sodhi S; Mahajan V
Expert Opin Ther Targets; 2009 Aug; 13(8):889-94. PubMed ID: 19606928
[TBL] [Abstract][Full Text] [Related]
7. Plasma lipid peroxidation and totalantioxidant status among dyslipidaemic and hypertensive Nigerians with high risk of coronary heart disease.
Ogunro PS; Balogun WO; Fadero FF; Idogun ES; Oninla SO; Elemile PO; Eziyi AK
West Afr J Med; 2009 Mar; 28(2):87-91. PubMed ID: 19761169
[TBL] [Abstract][Full Text] [Related]
8. Association between paraoxonase-1 activity and lipid peroxidation indicator levels in people living in the Antalya region with angiographically documented coronary artery disease.
Göçmen AY; Gümüşlü S; Semiz E
Clin Cardiol; 2004 Jul; 27(7):426-30. PubMed ID: 15298047
[TBL] [Abstract][Full Text] [Related]
9. Age, Sex, and Cardiovascular Risk Attributable to Lipoprotein Cholesterol Among Chinese Individuals with Coronary Artery Disease: A Case-Control Study.
Wu TT; Zheng YY; Yang YN; Li XM; Ma YT; Xie X
Metab Syndr Relat Disord; 2019 May; 17(4):223-231. PubMed ID: 30720383
[No Abstract] [Full Text] [Related]
10. Comparative effects of 10-mg versus 80-mg Atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary artery disease: results of the CAP (Comparative Atorvastatin Pleiotropic effects) study.
Bonnet J; McPherson R; Tedgui A; Simoneau D; Nozza A; Martineau P; Davignon J;
Clin Ther; 2008 Dec; 30(12):2298-313. PubMed ID: 19167589
[TBL] [Abstract][Full Text] [Related]
11. Relationship between plasma phospholipase A2 concentrations and lipoprotein subfractions in patients with stable coronary artery disease.
Xu RX; Zhang Y; Li XL; Li S; Guo YL; Dong Q; Liu G; Li JJ
Clin Chim Acta; 2015 Jun; 446():195-200. PubMed ID: 25934512
[TBL] [Abstract][Full Text] [Related]
12. Sialic acid and oxidizability of lipid and proteins and antioxidant status in patients with coronary artery disease.
Serdar Z; Yeşilbursa D; Dirican M; Sarandöl E; Serdar A
Cell Biochem Funct; 2007; 25(6):655-64. PubMed ID: 17006879
[TBL] [Abstract][Full Text] [Related]
13. Association between erythrocyte membrane fatty acids and biomarkers of dyslipidemia in the EPIC-Potsdam study.
Jacobs S; Schiller K; Jansen E; Fritsche A; Weikert C; di Giuseppe R; Boeing H; Schulze MB; Kröger J
Eur J Clin Nutr; 2014 Apr; 68(4):517-25. PubMed ID: 24569539
[TBL] [Abstract][Full Text] [Related]
14. Serum high-density lipoprotein-cholesterol levels modify the association between plasma levels of oxidatively modified low-density lipoprotein and coronary artery disease in men.
Zhang B; Bai H; Liu R; Kumagai K; Itabe H; Takano T; Saku K
Metabolism; 2004 Apr; 53(4):423-9. PubMed ID: 15045686
[TBL] [Abstract][Full Text] [Related]
15. Association of Genetically Predicted Lipid Levels With the Extent of Coronary Atherosclerosis in Icelandic Adults.
Björnsson E; Thorleifsson G; Helgadóttir A; Guðnason T; Guðbjartsson T; Andersen K; Grétarsdóttir S; Ólafsson Í; Tragante V; Ólafsson ÓH; Jónsdóttir B; Eyjólfsson GI; Sigurðardóttir Ó; Thorgeirsson G; Guðbjartsson DF; Thorsteinsdóttir U; Hólm H; Stefánsson K
JAMA Cardiol; 2020 Jan; 5(1):13-20. PubMed ID: 31746962
[TBL] [Abstract][Full Text] [Related]
16. Vaccenic acid and trans fatty acid isomers from partially hydrogenated oil both adversely affect LDL cholesterol: a double-blind, randomized controlled trial.
Gebauer SK; Destaillats F; Dionisi F; Krauss RM; Baer DJ
Am J Clin Nutr; 2015 Dec; 102(6):1339-46. PubMed ID: 26561632
[TBL] [Abstract][Full Text] [Related]
17. Association of plasma apolipoprotein CIII, high sensitivity C-reactive protein and tumor necrosis factor-α contributes to the clinical features of coronary heart disease in Li and Han ethnic groups in China.
Chen L; Sun M; Liu H; Ma L; Wang T; Li P; Lin M; Lin H; Chang P; Liu Y
Lipids Health Dis; 2018 Jul; 17(1):176. PubMed ID: 30053815
[TBL] [Abstract][Full Text] [Related]
18. Increased oxidative stress and decreased membrane fluidity in erythrocytes of CAD patients.
Pytel E; Olszewska-Banaszczyk M; Koter-Michalak M; Broncel M
Biochem Cell Biol; 2013 Oct; 91(5):315-8. PubMed ID: 24032681
[TBL] [Abstract][Full Text] [Related]
19. Increased circulating malondialdehyde-modified LDL levels in patients with coronary artery diseases and their association with peak sizes of LDL particles.
Tanaga K; Bujo H; Inoue M; Mikami K; Kotani K; Takahashi K; Kanno T; Saito Y
Arterioscler Thromb Vasc Biol; 2002 Apr; 22(4):662-6. PubMed ID: 11950707
[TBL] [Abstract][Full Text] [Related]
20. Genetic study of common variants at the Apo E, Apo AI, Apo CIII, Apo B, lipoprotein lipase (LPL) and hepatic lipase (LIPC) genes and coronary artery disease (CAD): variation in LIPC gene associates with clinical outcomes in patients with established CAD.
Baroni MG; Berni A; Romeo S; Arca M; Tesorio T; Sorropago G; Di Mario U; Galton DJ
BMC Med Genet; 2003 Sep; 4():8. PubMed ID: 12964943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
